Methods and compositions for preventing or treating ophthalmic conditions
First Claim
Patent Images
1. A method for treating an ophthalmic condition in a subject in need thereof, comprising administering to the subject a peptide represented by the formula D-Arg-2′
- 6′
-Dmt-Lys-Phe-NH2 or Phe-D-Arg-Phe-Lys-NH2, wherein the ophthalmic condition is selected from the group consisting of;
retinal edema and retinal vascular occlusions, and wherein the subject is diagnosed as having or suspected of having said ophthalmic condition.
5 Assignments
0 Petitions
Accused Products
Abstract
The disclosure generally describes methods of preventing or treating ophthalmic diseases or conditions in a mammalian subject, such as diabetic retinopathy, cataracts, retinitis pigmentosa, glaucoma, macular degeneration, choroidal neovascularization, retinal degeneration, and oxygen-induced retinopathy. The methods comprise administering an effective amount of an aromatic-cationic peptide to subjects in need thereof.
55 Citations
9 Claims
-
1. A method for treating an ophthalmic condition in a subject in need thereof, comprising administering to the subject a peptide represented by the formula D-Arg-2′
- 6′
-Dmt-Lys-Phe-NH2 or Phe-D-Arg-Phe-Lys-NH2, wherein the ophthalmic condition is selected from the group consisting of;
retinal edema and retinal vascular occlusions, and wherein the subject is diagnosed as having or suspected of having said ophthalmic condition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
- 6′
Specification